130 related articles for article (PubMed ID: 31006389)
1. Critical review of the follow-up protocol for head and neck cancer patients.
Kytö E; Haapio E; Minn H; Irjala H
J Laryngol Otol; 2019 May; 133(5):424-429. PubMed ID: 31006389
[TBL] [Abstract][Full Text] [Related]
2. The value of routine follow-up after treatment for head and neck cancer. A national survey from DAHANCA.
Pagh A; Vedtofte T; Lynggaard CD; Rubek N; Lonka M; Johansen J; Andersen E; Kristensen CA; von Buchwald C; Andersen M; Godballe C; Overgaard J; Grau C
Acta Oncol; 2013 Feb; 52(2):277-84. PubMed ID: 23320772
[TBL] [Abstract][Full Text] [Related]
3. Surveillance of Patients with Head and Neck Cancer with an Intensive Clinical and Radiologic Follow-up.
Imbimbo M; Alfieri S; Botta L; Bergamini C; Gloghini A; Calareso G; Orlandi E; Iacovelli NA; Guzzo M; Granata R; Resteghini C; Locati L; Volpi CC; Licitra L; Bossi P
Otolaryngol Head Neck Surg; 2019 Oct; 161(4):635-642. PubMed ID: 31286827
[TBL] [Abstract][Full Text] [Related]
4. A longitudinal study of follow-up activities after curative treatment for head and neck cancer.
Pagh A; Grau C; Overgaard J
Acta Oncol; 2015 May; 54(5):813-9. PubMed ID: 25907822
[TBL] [Abstract][Full Text] [Related]
5. Survival in second primary malignancies of patients with head and neck cancer.
Di Martino E; Sellhaus B; Hausmann R; Minkenberg R; Lohmann M; Esthofen MW
J Laryngol Otol; 2002 Oct; 116(10):831-8. PubMed ID: 12437840
[TBL] [Abstract][Full Text] [Related]
6. Follow-up after curative treatment for oral squamous cell carcinoma. A critical appraisal of the guidelines and a review of the literature.
Brands MT; Brennan PA; Verbeek ALM; Merkx MAW; Geurts SME
Eur J Surg Oncol; 2018 May; 44(5):559-565. PubMed ID: 29433990
[TBL] [Abstract][Full Text] [Related]
7. Effect of coronavirus disease 2019 on recurrences and follow up of head and neck squamous cell carcinoma.
Kytö E; Haapio E; Kinnunen I; Irjala H
J Laryngol Otol; 2021 Apr; 135(4):344-347. PubMed ID: 33752762
[TBL] [Abstract][Full Text] [Related]
8. The value of follow-up in patients treated for squamous cell carcinoma of the head and neck.
Boysen M; Lövdal O; Tausjö J; Winther F
Eur J Cancer; 1992; 28(2-3):426-30. PubMed ID: 1591057
[TBL] [Abstract][Full Text] [Related]
9. A review of telephone consultations for head and neck cancer follow up: a patient satisfaction survey.
Stewart R; Collins L; Kerr B; Gray G; Devlin B; Black M; Ullah R
J Laryngol Otol; 2021 Sep; 135(9):815-819. PubMed ID: 34294168
[TBL] [Abstract][Full Text] [Related]
10. Follow-up after treatment for head and neck cancer: United Kingdom National Multidisciplinary Guidelines.
Simo R; Homer J; Clarke P; Mackenzie K; Paleri V; Pracy P; Roland N
J Laryngol Otol; 2016 May; 130(S2):S208-S211. PubMed ID: 27841136
[TBL] [Abstract][Full Text] [Related]
11. Self-reported Symptoms to Monitor Recurrent Head and Neck Cancer-Analysis of 1,678 Cases.
Boysen ME; Zätterström UK; Evensen JF
Anticancer Res; 2016 Jun; 36(6):2849-54. PubMed ID: 27272796
[TBL] [Abstract][Full Text] [Related]
12. Outpatient follow-up appointments for patients having curative treatment for cancer of the head and neck: are the current arrangements in need of change?
Kanatas A; Bala N; Lowe D; Rogers SN
Br J Oral Maxillofac Surg; 2014 Oct; 52(8):681-7. PubMed ID: 25037165
[TBL] [Abstract][Full Text] [Related]
13. The follow-up of patients with head and neck cancer: an analysis of 1,039 patients.
Kothari P; Trinidade A; Hewitt RJD; Singh A; O'Flynn P
Eur Arch Otorhinolaryngol; 2011 Aug; 268(8):1191-1200. PubMed ID: 21193920
[TBL] [Abstract][Full Text] [Related]
14. Conditional Survival-Based "Abbreviated" Routine Cancer Surveillance for Pathologic Stage IB Melanoma.
Kukar M; Gabriel E; May R; Cho E; Lichtenthal M; Groman A; Skitzki J; Francescutti V; Kane JM
Am Surg; 2017 Nov; 83(11):1256-1262. PubMed ID: 29183528
[TBL] [Abstract][Full Text] [Related]
15. 'When will I see you again?' Using local recurrence data to develop a regimen for routine surveillance in post-treatment head and neck cancer patients.
Lester SE; Wight RG
Clin Otolaryngol; 2009 Dec; 34(6):546-51. PubMed ID: 20070764
[TBL] [Abstract][Full Text] [Related]
16. Rates of symptomatology are lower in recurrent sinonasal malignancy than in other recurrent cancers of the head and neck: a multi-institutional study.
Workman AD; Velasquez N; Khan NI; Borchard NA; Kuan EC; Palmer JN; Wang EW; Patel ZM; Adappa ND
Int Forum Allergy Rhinol; 2019 Jun; 9(6):688-694. PubMed ID: 30768764
[TBL] [Abstract][Full Text] [Related]
17. Assessment and topographic characterization of locoregional recurrences in head and neck tumours.
Ferreira BC; Marques RV; Khouri L; Santos T; Sá-Couto P; do Carmo Lopes M
Radiat Oncol; 2015 Feb; 10():41. PubMed ID: 25889988
[TBL] [Abstract][Full Text] [Related]
18. [Routine follow-up in patients treated of head and neck cancer].
Wierzbicka M; Waśniewska E; Jackowska J; Leszczyńska M; Szyfter W
Otolaryngol Pol; 2012; 66(2):138-47. PubMed ID: 22500505
[TBL] [Abstract][Full Text] [Related]
19. The value of periodic follow-up in the detection of recurrences after radical treatment in locally advanced head and neck cancer.
Flynn CJ; Khaouam N; Gardner S; Higgins K; Enepekides D; Balogh J; MacKenzie R; Singh S; Davidson J; Poon I
Clin Oncol (R Coll Radiol); 2010 Dec; 22(10):868-73. PubMed ID: 20650620
[TBL] [Abstract][Full Text] [Related]
20. Correlation between subjective evaluation of symptoms and objective findings in early recurrent head and neck squamous cell carcinoma.
Nisa L; La Macchia R; Boujelbene N; Sandu K; Khanfir K; Giger R
JAMA Otolaryngol Head Neck Surg; 2013 Jul; 139(7):687-93. PubMed ID: 23788001
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
